Advanced Biomedical Technologies, Inc.
ABMT · OTC
7/31/2022 | 4/30/2022 | 1/31/2022 | 10/31/2021 | |
|---|---|---|---|---|
| Revenue | -$0 | -$0 | $0 | $0 |
| % Growth | -4,742.2% | -100% | 127.6% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | 147.6% | 6,584.3% | 85.6% | 73.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | -$0 | -$0 | $0 | -$0 |
| % Margin | 2,162.8% | 105,165.7% | 51.9% | -65.7% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$0 | -$0 | $0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | $0 | -$0 |
| % Margin | 3,842.6% | 186,752.9% | 20.6% | -137.1% |
| EPS | -0.003 | -0.003 | 0.001 | -0.002 |
| % Growth | 0% | -437.5% | 133.3% | – |
| EPS Diluted | -0.003 | -0.003 | 0.001 | -0.002 |
| Weighted Avg Shares Out | 71 | 71 | 71 | 71 |
| Weighted Avg Shares Out Dil | 71 | 71 | 71 | 71 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | $0 | -$0 |
| % Margin | 2,105% | 97,856.9% | 52.4% | -65.8% |